Literature DB >> 25581336

Association of killer cell immunoglobulin-like receptor and human leucocyte antigen-Cw gene combinations with systemic lupus erythematosus.

Y Hou1, C Zhang, D Xu, H Sun.   

Abstract

Killer cell immunoglobulin-like receptors (KIRs) are a diverse family of activating and inhibitory receptors expressed on natural killer (NK) cells and T cells, the genes of which show extreme polymorphism. Some KIRs bind to human leucocyte antigen (HLA) class I subgroups, and genetic interactions between KIR genes and their ligand HLA have been shown to be associated with several autoimmune diseases. The present study aimed to investigate whether the combinations of KIR genes and HLA-Cw ligands associate with the susceptibility of systemic lupus erythematosus (SLE). Polymerase chain reaction using sequence-specific primers was used to determine the genotypes of KIR genes and HLA-Cw alleles. We found that the frequencies of HLA-Cw07 were statistically significantly higher in the patient group than those in the control group (P = 0·009). KIR2DS1(+) HLA(-) Cw(Lys) was more common in subjects with SLE compared to control subjects (P = 0·015). In addition, the frequency of KIR2DS1 was increased in SLE when KIR2DL1/HLA-Cw are absent, and the difference was significant (P = 0·001). KIR genotype and HLA ligand interaction may potentially influence the threshold for NK (and/or T) cell activation mediated through activating receptors, thereby contributing to the pathogenesis of SLE.
© 2015 British Society for Immunology.

Entities:  

Keywords:  genes; killer cell immunoglobulin-like receptors; systemic lupus erythematosus

Mesh:

Substances:

Year:  2015        PMID: 25581336      PMCID: PMC4408160          DOI: 10.1111/cei.12582

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

Review 1.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.

Authors:  Baptiste Hervier; Vivien Beziat; Julien Haroche; Alexis Mathian; Pierre Lebon; Pascale Ghillani-Dalbin; Lucile Musset; Patrice Debré; Zahir Amoura; Vincent Vieillard
Journal:  Arthritis Rheum       Date:  2011-06

4.  Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

Authors:  Yasutaka Kimoto; Takahiko Horiuchi; Hiroshi Tsukamoto; Chikako Kiyohara; Hiroki Mitoma; Ayumi Uchino; Isao Furugo; Seiji Yoshizawa; Akira Ueda; Shinichi Harashima; Takuya Sawabe; Tomoko Tahira; Kenshi Hayashi; Shigeru Yoshizawa; Terufumi Shimoda; Koichi Akashi; Mine Harada
Journal:  Rheumatology (Oxford)       Date:  2010-04-05       Impact factor: 7.580

5.  Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

Authors:  Yu-Lian Jiao; Bing-Chang Zhang; Li You; Jian-Feng Li; Jie Zhang; Chun-Yan Ma; Bin Cui; Lai-Cheng Wang; Zi-Jiang Chen; Yue-Ran Zhao
Journal:  J Clin Immunol       Date:  2010-07-21       Impact factor: 8.317

Review 6.  A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis.

Authors:  Takahiko Horiuchi; Chikako Kiyohara; Hiroshi Tsukamoto; Takuya Sawabe; Isao Furugo; Seiji Yoshizawa; Akira Ueda; Yoshifumi Tada; Tadashi Nakamura; Yasutaka Kimoto; Hiroki Mitoma; Shinichi Harashima; Shigeru Yoshizawa; Terufumi Shimoda; Seiich Okamura; Kohei Nagasawa; Mine Harada
Journal:  Ann Rheum Dis       Date:  2006-10-06       Impact factor: 19.103

Review 7.  Hanging in the balance. KIR and their role in disease.

Authors:  Anthony P Williams; Andrew R Bateman; Salim I Khakoo
Journal:  Mol Interv       Date:  2005-08

8.  Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.

Authors:  P H Salim; M Jobim; M Bredemeier; J A B Chies; J Schlottfeldt; J C T Brenol; L F Jobim; R M Xavier
Journal:  Clin Exp Immunol       Date:  2010-01-15       Impact factor: 4.330

9.  KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma.

Authors:  F Pellett; F Siannis; I Vukin; P Lee; M B Urowitz; D D Gladman
Journal:  Tissue Antigens       Date:  2007-04

10.  An increased frequency of NK cell receptor and HLA-C group 1 combinations in early-onset type 1 diabetes.

Authors:  K L Mehers; A E Long; A R van der Slik; R J Aitken; V Nathwani; F S Wong; S Bain; G Gill; B O Roep; P J Bingley; K M Gillespie
Journal:  Diabetologia       Date:  2011-09-10       Impact factor: 10.122

View more
  8 in total

Review 1.  KIR and HLA under pressure: evidences of coevolution across worldwide populations.

Authors:  Danillo G Augusto; Maria Luiza Petzl-Erler
Journal:  Hum Genet       Date:  2015-06-23       Impact factor: 4.132

Review 2.  Missing or altered self: human NK cell receptors that recognize HLA-C.

Authors:  Hugo G Hilton; Peter Parham
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

3.  The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.

Authors:  Jülide Duymaz Tozkır; Hilmi Tozkır; Hakan Gürkan; Salim Dönmez; Damla Eker; Gülsüm Emel Pamuk; Ömer Nuri Pamuk
Journal:  Clin Rheumatol       Date:  2016-03-09       Impact factor: 2.980

4.  Activation status of CD56dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus.

Authors:  Manman Liu; Junli Liu; Xiaoyan Zhang; Yichuan Xiao; Gengru Jiang; Xinfang Huang
Journal:  Clin Rheumatol       Date:  2020-08-14       Impact factor: 2.980

5.  Association between killer cell immunoglobulin-like receptor (KIR) polymorphisms and systemic lupus erythematosus (SLE) in populations: A PRISMA-compliant meta-analysis.

Authors:  Hui-Ling Liang; Shu-Juan Ma; Hong-Zhuan Tan
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness.

Authors:  Filip Segerberg; Christian Lundtoft; Sarah Reid; Karin Hjorton; Dag Leonard; Gunnel Nordmark; Mattias Carlsten; Niklas Hagberg
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

7.  Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis.

Authors:  Hannah C Jeffery; Manjit K Braitch; Chris Bagnall; James Hodson; Louisa E Jeffery; Rebecca E Wawman; Lin Lee Wong; Jane Birtwistle; Helen Bartlett; Ansgar W Lohse; Gideon M Hirschfield; Jessica Dyson; David Jones; Stefan G Hubscher; Paul Klenerman; David H Adams; Ye H Oo
Journal:  Hepatol Commun       Date:  2018-02-26

8.  Phenotypic and Functional Changes in Peripheral Blood Natural Killer Cells in Crohn Disease Patients.

Authors:  Suzanne Samarani; Patrick Sagala; Prevost Jantchou; Guy Grimard; Christophe Faure; Colette Deslandres; Devendra K Amre; Ali Ahmad
Journal:  Mediators Inflamm       Date:  2020-02-19       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.